HDII (Hypertension Diagnostics) Cash-to-Debt: 0.02 (As of Sep. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hypertension Diagnostics Cash-to-Debt?

Hypertension Diagnostics HDII -99.00% Cash-to-Debt is 0.02 as of Sep. 2019.

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Hypertension Diagnostics's cash to debt ratio for the quarter that ended in Sep. 2019 was 0.02.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Hypertension Diagnostics couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2019.

The historical rank and industry rank for Hypertension Diagnostics's Cash-to-Debt or its related term are showing as below:

HDII's Cash-to-Debt is not ranked *
in the Diversified Financial Services industry.
Industry Median: 7.99
* Ranked among companies with meaningful Cash-to-Debt only.

Hypertension Diagnostics  (OTCPK:HDII) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Hypertension Diagnostics Cash-to-Debt Related Terms

Hypertension Diagnostics Cash-to-Debt Historical Data

* Premium members only.

The historical data trend for Hypertension Diagnostics's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Hypertension Diagnostics Cash-to-Debt Chart

Hypertension Diagnostics Annual Data
Trend Jun06 Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Dec16 Dec17 Dec18
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only No Debt 0.12 0.05 0.07 0.02

Hypertension Diagnostics Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Dec16 Dec17 Dec18 Mar19 Jun19 Sep19
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.07 0.02 0.02 0.02 0.02

HDII vs ESTRF, OCLN, PTOI: Cash-to-Debt Comparison

For the Shell Companies subindustry, Hypertension Diagnostics's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypertension Diagnostics Cash-to-Debt vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Hypertension Diagnostics's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Hypertension Diagnostics's Cash-to-Debt falls into.


Hypertension Diagnostics Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Hypertension Diagnostics's Cash to Debt Ratio for the fiscal year that ended in Dec. 2018 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=0.086 / (0 + 4.685)
=0.02

Hypertension Diagnostics's Cash to Debt Ratio for the quarter that ended in Sep. 2019 is calculated as:

Cash to Debt Ratio= Cash, Cash Equivalents, Marketable Securities / Total Debt
= Cash, Cash Equivalents, Marketable Securities / (Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation)
=0.086 / (0 + 4.685)
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash-to-Debt →
What does a Cash-to-Debt of 0.02 mean?
Hypertension Diagnostics (HDII) has a Cash-to-Debt of 0.02 as of Sep. 2019.
Is Hypertension Diagnostics' Cash-to-Debt too high?
Hypertension Diagnostics' current Cash-to-Debt is 0.02. The Diversified Financial Services industry median Cash-to-Debt is 7.99. Hypertension Diagnostics' value of 0.02 is 99.7% below this industry median.
How does Hypertension Diagnostics' Cash-to-Debt compare to ESTRF and OCLN?
Hypertension Diagnostics' Cash-to-Debt of 0.02 can be compared against companies in the Diversified Financial Services industry. The industry median Cash-to-Debt is 7.99. Hypertension Diagnostics' value of 0.02 is 99.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Diversified Financial Services company?
The median Cash-to-Debt among Diversified Financial Services companies is 7.99, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hypertension Diagnostics's current Cash-to-Debt of 0.02 is 99.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Diversified Financial Services industry, the median Cash-to-Debt is 7.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypertension Diagnostics's current Cash-to-Debt is 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypertension Diagnostics stock overvalued right now?
Hypertension Diagnostics (HDII) has a current Cash-to-Debt of 0.02. The current Cash-to-Debt is 0.02 and 99.7% below the Diversified Financial Services industry median of 7.99. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Hypertension Diagnostics (HDII), the current Cash-to-Debt is 0.02 as of Sep. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypertension Diagnostics Business Description

Address 550 Highway 7 Unit 316, Ontario, ON, CAN, L4B324
Hypertension Diagnostics Inc is a shell company.